Search

everythinglearnresearchcommunity

for

Search:↓

Probe detects finasteride with high selectivity and low detection limit.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Patients with Shwachman-Diamond syndrome often get misdiagnosed due to a wide range of symptoms, including immune system problems and bone abnormalities.

Blocking interferon-gamma might help treat various autoimmune diseases.

Plant-made bFGF helps cells grow and boosts collagen.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

Syphilis is becoming more common and remains a major health problem due to challenges in prevention and treatment.

Understanding how acne develops in different diseases could lead to new treatments.

Stopping S100A3 activity slows down hair growth in mice.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

A 10-month-old boy with a rare combination of genetic conditions has severe immune deficiency and treatment challenges.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Physical activity, height, and smoking affect prostate cancer risk.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

A woman with severe angioedema improved significantly after treatment with rituximab.

A specific RNA molecule, circCOL1A1, affects the growth and quality of goat hair by interacting with miR-149-5p and influencing cell growth pathways.

The document is a detailed guide on skin conditions and treatments for dermatologists.

The document lists various dermatology topics, treatments, and diagnostic methods.

Modified stem cells that overexpress a specific protein can improve hair growth and reduce hair abnormalities in mice.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

A fungus ball in the lung can cause coughing up blood in SLE patients.

Atypical symptoms in lupus can indicate different kidney issues.